Education
About Us
Working with TipRanks
Follow Us
Clarivate (CLVT)
NYSE:CLVT
CLVT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.04 - $7.30
Previous CloseN/A
Volume814.08K
Average Volume (3M)6.30M
Market Cap
$2.47B
Enterprise Value$7.87B
Total Cash (Recent Filing)$295.20M
Total Debt (Recent Filing)$4.59B
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Apr 29, 2025EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding688,956,100
10 Day Avg. Volume4,909,814
30 Day Avg. Volume6,295,260
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap3.18
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.66
Enterprise Value/Ebitda16.78
Forecast
1Y Price Target
$5.39Price Target Upside28.03% Upside
Rating ConsensusHold
Number of Analyst Covering8
---
Clarivate News
PremiumThe Fly
Clarivate rises 17.5%
PremiumThe Fly
Clarivate rises 12.5%
PremiumThe Fly
Clarivate rises 22.3%
PremiumCompany Announcements
Clarivate Plc Reports Q1 2025 Financial Results
PremiumCompany Announcements
Clarivate Plc’s Optimistic Q1 Earnings Call Analysis---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceClarivate's first-quarter revenue was significantly above analyst estimates and consensus, leading to higher adjusted EBITDA, margin, and EPS.
Revenue GrowthImprovement in patent and trademark renewal volumes largely drove strength in recurring revenue.
Bears Say
Management ChallengesCLVT is now under its third CEO in as many years, who will have a significant lift on his hands in order to turn around the business.
Organic GrowthCLVT's business lines saw further deterioration in organic growth with all segments missing expectations.
Strategic ChangesValue Creation Plan likely to mean significant changes to the asset mix going forward, though do not expect asset sales to create value.
---
Ownership Overview
7.19% Insiders
13.72% Mutual Funds
10.27% Other Institutional Investors
63.58% Public Companies and
Individual Investors
CLVT FAQ
What was Clarivate’s price range in the past 12 months?
Clarivate lowest stock price was $3.04 and its highest was $7.30 in the past 12 months.
What is Clarivate’s market cap?
Clarivate’s market cap is $2.47B.
When is Clarivate’s upcoming earnings report date?
Clarivate’s upcoming earnings report date is Apr 29, 2025 which is yesterday.
How were Clarivate’s earnings last quarter?
Clarivate released its earnings results on Feb 19, 2025. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.203 by $0.007.
Is Clarivate overvalued?
According to Wall Street analysts Clarivate’s price is currently Undervalued.
Does Clarivate pay dividends?
Clarivate does not currently pay dividends.
What is Clarivate’s EPS estimate?
Clarivate’s EPS estimate is 0.12.
How many shares outstanding does Clarivate have?
Clarivate has 688,956,100 shares outstanding.
What happened to Clarivate’s price movement after its last earnings report?
Clarivate reported an EPS of $0.21 in its last earnings report, beating expectations of $0.203. Following the earnings report the stock price went up 17.27%.
Which hedge fund is a major shareholder of Clarivate?
Currently, no hedge funds are holding shares in CLVT
---
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.39 (28.03% Upside)
$5.39 (28.03% Upside)
Blogger Sentiment
Neutral
CLVT Sentiment 50%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 31.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.57%
12-Months-Change
Fundamentals
Return on Equity
-11.44%
Trailing 12-Months
Asset Growth
-9.57%
Trailing 12-Months
Company Description
Clarivate
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
---
CLVT Company Deck
---
CLVT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights Clarivate's strong Q1 performance with improved revenue growth, increased renewal rates, and successful multiyear deals, alongside ongoing product innovation. However, challenges include a net loss due to restructuring expenses, declines in transactional revenue, and potential risks from US government funding changes. Despite these challenges, the company remains optimistic about its strategic direction.Read More>---
CLVT Stock 12 Month Forecast
Average Price Target
$5.39
▲(28.03% Upside)
Technical Analysis
---